Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00883142 · ClinicalTrials.gov registry record

Functional and Physiological Responses to Lokomat Therapy (Pilot Study)

A clinical trial of Stroke and Multiple Sclerosis, sponsored by US Department of Veterans Affairs.

Completed
Registry status
27
Enrollment target
1
Study location

NCT00883142 is a study of Stroke and Multiple Sclerosis that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 27 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00883142, a study of Stroke and Multiple Sclerosis, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
27 participants
Enrollment target
1
Study location

Study Summary

Individuals with neurological deficiencies such as those who have spinal cord injury, stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis often lose their ability to ambulate over ground. Loss of functional mobility not only impedes everyday life, but may also affect many systems and organs in the body. The investigators are interested in obtaining a wide variety of data in order to obtain a better understanding of changes that occur as a result of receiving Lokomat therapy. The investigators will be studying body composition, cardiac, pulmonary, endocrine, metabolic, and molecular changes after a 12-week clinical therapy program.

Study Locations (1)

New York

  • VA Medical Center, Bronx - The Bronx

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2006-10
Est. Completion 2013-03

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00883142

The ClinicalTrials.gov registry entry for NCT00883142 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT00883142 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00883142 about?

NCT00883142 is a clinical study titled "Functional and Physiological Responses to Lokomat Therapy (Pilot Study)". Individuals with neurological deficiencies such as those who have spinal cord injury, stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis often lose their ability to ambulate over ground. Loss of functional mobility not only impedes everyday life, but may also affect many sys...

What is the current status of trial NCT00883142?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2006-10. Estimated completion is 2013-03.

What conditions does trial NCT00883142 study?

This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, Spinal Cord Injuries.

Who is sponsoring clinical trial NCT00883142?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00883142 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.